| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/06/2006 | CA2154788C Anticoagulant composition |
| 06/06/2006 | CA2154572C Use of riluzole for the treatment of neuro-sida |
| 06/06/2006 | CA2145514C Process for the preparation of 9-amino camptothecin |
| 06/06/2006 | CA2136903C Acetic acid derivatives |
| 06/06/2006 | CA2136356C 1,2,3-triazole and imidazole compounds and their antitumor use |
| 06/06/2006 | CA2133080C Calanolide antiviral compounds, compositions and uses thereof |
| 06/06/2006 | CA2116980C Chimeric and/or growth-restricted flaviviruses |
| 06/01/2006 | WO2006058316A1 Dosage regimen of an s1p receptor agonist |
| 06/01/2006 | WO2006058303A2 Modulators of muscarinic receptors |
| 06/01/2006 | WO2006058298A2 A method of administering anti-angiogenic agents and a method of treating disease using same |
| 06/01/2006 | WO2006058201A2 Heterocyclic and bicyclic compounds, compositions and methods |
| 06/01/2006 | WO2006058199A1 Methods of modulating high-density lipoprotein cholesterol levels and pharmaceutical formulations for the same |
| 06/01/2006 | WO2006058140A2 Capsaicinoid gel formulation and uses thereof |
| 06/01/2006 | WO2006058121A1 Crystalline forms of 3'-tert-butyl-3'-n-tert-butyloxycarbonyl-4-deacetyl-3'-dephenyl-3'-n-debenzoyl-4-o-methoxycarbonyl-paclitaxel |
| 06/01/2006 | WO2006058120A1 Bicyclic inhibitors or rho kinase |
| 06/01/2006 | WO2006058109A1 Triple natural polymer viscoelastic composition |
| 06/01/2006 | WO2006058080A1 Treatment of inflammatory bowel disease |
| 06/01/2006 | WO2006058074A1 Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases |
| 06/01/2006 | WO2006058073A2 Pharmaceutical compositions comprising a selective cox-2 inhibitor and a diuretic |
| 06/01/2006 | WO2006058064A2 Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 06/01/2006 | WO2006058063A1 2,3,4-substituted-cyclopentanones as therapeutic agents |
| 06/01/2006 | WO2006058059A2 Composition comprising a sustained release coating or matrix and an nmda receptor antagonist, method for administration such nmda antagonist to a subject |
| 06/01/2006 | WO2006058029A2 Method of treating opioid dependency |
| 06/01/2006 | WO2006058023A2 Treatment of stroke with histamine h3 inverse agonists or histamine h3 antagonists |
| 06/01/2006 | WO2006058016A2 Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 06/01/2006 | WO2006058012A2 Gonadotropin releasing hormone receptor antagonists |
| 06/01/2006 | WO2006058008A1 Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury |
| 06/01/2006 | WO2006058007A2 Jnk inhibitors for treatment of cns injury |
| 06/01/2006 | WO2006057998A1 Binary antitumor compositions platinum (iv) derivatives |
| 06/01/2006 | WO2006057983A1 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/01/2006 | WO2006057977A2 Cycloalkyl piperidine tachykinin receptor antagonists |
| 06/01/2006 | WO2006057972A1 Process for preparing novel crystalline forms of (2s)-1-[[(7r)-7-(3,4-dichlorophenyl)-4,7-dihydro-5-methylpyrazolo[1,5]pyrimidine-6-yl]carbonyl]-2-(4-fluorophenyl) pyrrolidine, novel stable forms produced therein and formulations |
| 06/01/2006 | WO2006057961A1 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors |
| 06/01/2006 | WO2006057955A2 Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 06/01/2006 | WO2006057952A2 Small particle copper pyrithione |
| 06/01/2006 | WO2006057950A2 4-phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 06/01/2006 | WO2006057946A2 Tubulin binding anti cancer agents and prodrugs thereof |
| 06/01/2006 | WO2006057945A2 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/01/2006 | WO2006057932A2 2-METHYLENE-18,19-DINOR-1α-HYDROXY-HOMOPREGNACALCIFEROL AND ITS USES |
| 06/01/2006 | WO2006057922A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 06/01/2006 | WO2006057921A2 Piperidinyl piperidine tachykinin receptor antagonists |
| 06/01/2006 | WO2006057912A2 Rasagiline orally disintegrating compositions |
| 06/01/2006 | WO2006057902A2 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses |
| 06/01/2006 | WO2006057901A2 2-METHYLENE-19-NOR-1α-HYDROXY-17-ENE-HOMOPREGNACALCIFEROL AND ITS USES |
| 06/01/2006 | WO2006057900A2 17,20(z)-dehydro vitamin d analogs and their uses |
| 06/01/2006 | WO2006057899A2 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses |
| 06/01/2006 | WO2006057886A2 2-METHYLENE-19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND ITS USES |
| 06/01/2006 | WO2006057885A2 17,20(e)-dehydro vitamin d analogs and their uses |
| 06/01/2006 | WO2006057884A2 2α-METHYL AND 2ß-METHYL ANALOGS OF 19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND THEIR USES |
| 06/01/2006 | WO2006057870A1 Potentiators of glutamate receptors |
| 06/01/2006 | WO2006057869A1 Potentiators of glutamate receptors |
| 06/01/2006 | WO2006057868A1 Antithrombotic diamides |
| 06/01/2006 | WO2006057860A1 Potentiators of glutamate receptors |
| 06/01/2006 | WO2006057859A1 An implant for intraocular drug delivery |
| 06/01/2006 | WO2006057845A1 Aromatic ether derivatives useful as thrombin inhibitors |
| 06/01/2006 | WO2006057769A2 Method of delivering nasal spray |
| 06/01/2006 | WO2006057674A2 COMPOSITIONS AND METHODS FOR EX VIVO PRESERVATION OF BLOOD VESSELS FOR VASCULAR GRAFTS USING ANALOGUES OF cAMP AND cGMP |
| 06/01/2006 | WO2006057629A1 Agent for prophylaxis and treatment of a human reproductive system disorders filomek and method for the production thereof |
| 06/01/2006 | WO2006057616A1 A composition comprising at least 3 different diols |
| 06/01/2006 | WO2006057546A1 Use of dexrazoxane in the treatment of acute cerebral ischemia |
| 06/01/2006 | WO2006057501A1 N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}benzamidine 2 methansulfonic acid salt |
| 06/01/2006 | WO2006057460A1 Nitrogen-containing fused ring compound and use thereof |
| 06/01/2006 | WO2006057448A1 Arylalkanoic acid derivative |
| 06/01/2006 | WO2006057432A1 Conjunctival filtration bleb forming agent and use thereof |
| 06/01/2006 | WO2006057429A1 Method of changing morphology of block copolymer |
| 06/01/2006 | WO2006057397A1 (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4homopiperazine hydrochloride dihydrate |
| 06/01/2006 | WO2006057346A1 Ameliorant for renal insufficiency |
| 06/01/2006 | WO2006057270A1 Nitrogeneous tricyclic compound |
| 06/01/2006 | WO2006057211A1 Therapeutic agent for drug dependence |
| 06/01/2006 | WO2006057209A1 Pharmaceutical composition having action of lowering blood free fatty acid |
| 06/01/2006 | WO2006057154A1 Efficacy enhancing agent for anticancer drug |
| 06/01/2006 | WO2006057152A1 Therapeutic agent for diabetes comprising protease-inhibiting compound |
| 06/01/2006 | WO2006057073A1 Athletic ability enhancing composition |
| 06/01/2006 | WO2006057011A2 Use of chitosan for stimulating bone healing and bone formation |
| 06/01/2006 | WO2006056884A1 N- [ (3s)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors |
| 06/01/2006 | WO2006056877A2 Diazepine oxazolidinones as antibacterial agents |
| 06/01/2006 | WO2006056874A1 Salt form |
| 06/01/2006 | WO2006056863A1 Pyrido’2, 3-d!pyrimidines as anti-inflammatory agents |
| 06/01/2006 | WO2006056854A1 Dibenzyl amine compounds and derivatives |
| 06/01/2006 | WO2006056848A1 Octahydropyrrolo[3,4-c]pyrrole derivatives |
| 06/01/2006 | WO2006056823A1 Modulating retinal pigmented epithelium permeation by inhibiting or activating vegfr-1 |
| 06/01/2006 | WO2006056815A1 Indole-2-carboxylic acid amides |
| 06/01/2006 | WO2006056801A1 Composition comprising a polysaccharide with bacteria blocking action |
| 06/01/2006 | WO2006056800A1 Use of phospholipids for wound healing |
| 06/01/2006 | WO2006056794A1 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy |
| 06/01/2006 | WO2006056783A2 Structured phospholipids for treating autoimmune and neurodegenerative diseases |
| 06/01/2006 | WO2006056770A1 Extended release pharmaceutical composition of celecoxib |
| 06/01/2006 | WO2006056760A1 A combination of n-(3-metoxy-5-methylpyrazin-2-yl)-2-(4-`1,3,4-oxadiazol-2-yl!phenyl)pyridine-3-sulphonamide and an anti-mitotic agent for the treatment of cancer |
| 06/01/2006 | WO2006056759A1 Modulation of blood clotting |
| 06/01/2006 | WO2006056752A1 Phenoxyacetic acid derivatives useful for treating respiratory diseases |
| 06/01/2006 | WO2006056697A1 Substituted thieno[2,3-c]pyrazoles, method for the preparation thereof, compositions containing them and use thereof |
| 06/01/2006 | WO2006056696A2 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof |
| 06/01/2006 | WO2006056695A1 Bengamides with a substituted caprolactame cycle, method for the preparation thereof, compositions containing them and use thereof |
| 06/01/2006 | WO2006056636A1 N-n-acyloxypropyl lysine methyl ester- and n,n-bis(n- acyloxypropyl)lysine methyl ester-type compounds and use thereof as surface-active agents with an antimicrobial activity |
| 06/01/2006 | WO2006056607A1 Substituted pteridines for treating inflammatory diseases |
| 06/01/2006 | WO2006056604A1 Levodopa glycosyl derivatives, methods of preparation and use |
| 06/01/2006 | WO2006056600A1 Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic a ivity |
| 06/01/2006 | WO2006056527A1 Inhalation medicament containing an anticholinesterase drug, salmeterol and a steroid selected from the ciclesonide or mometasone furoate group |
| 06/01/2006 | WO2006056526A1 Inhalation medicament containing a novel anticholinesterase drug, formoterol and a steroid |
| 06/01/2006 | WO2006056479A1 Sly1 inhibitors in transplantation |